Suppr超能文献

CD44R1黏附分子在结肠癌及转移灶中的表达。

Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

作者信息

Tanabe K K, Ellis L M, Saya H

机构信息

Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston.

出版信息

Lancet. 1993 Mar 20;341(8847):725-6. doi: 10.1016/0140-6736(93)90490-8.

Abstract

CD44 is a cell surface adhesion molecule postulated to control lymphocyte recirculation by facilitating entry into lymphoid tissue. Tumour cells transfected to overexpress the epithelial variant CD44R1 readily gain access to lymph nodes and distant metastatic sites in animal models, possibly by mimicking circulating lymphocytes. To investigate if human tumours display altered CD44 expression we performed reverse transcriptase a polymerase chain reaction (PCR) analysis of CD44 in 49 specimens from normal colonic mucosa, primary colon and rectal tumours, normal liver, and metastases of 20 patients. The haematopoietic variant CD44H was the principal isoform amplified in all of the specimens, However, 12/14 primary tumours and 16/16 metastatic potential. Moreover, the relative increase with only 2 of 13 normal mucosa specimens. This increase in CD44R1 relative to CD44H expressed by human colon carcinoma cells may increase their metastatic potential. Moreover, the relative increase in PCR amplification of CD44R1 compared with that of CD44H may provide a sensitive method for detecting primary and metastatic colon carcinoma cells in small biopsy specimens.

摘要

CD44是一种细胞表面黏附分子,据推测它可通过促进淋巴细胞进入淋巴组织来控制淋巴细胞再循环。在动物模型中,转染后过表达上皮变异体CD44R1的肿瘤细胞很容易进入淋巴结和远处转移部位,这可能是通过模仿循环淋巴细胞来实现的。为了研究人类肿瘤是否表现出CD44表达的改变,我们对20例患者的49份标本进行了CD44的逆转录聚合酶链反应(PCR)分析,这些标本来自正常结肠黏膜、原发性结肠癌和直肠癌、正常肝脏以及转移灶。造血变异体CD44H是所有标本中扩增出的主要异构体。然而,14例原发性肿瘤中有12例以及16例转移灶中有16例出现了CD44R1相对于CD44H的相对增加,而13份正常黏膜标本中只有2份出现这种情况。人类结肠癌细胞中CD44R1相对于CD44H的这种增加可能会增加其转移潜能。此外,与CD44H相比,CD44R1的PCR扩增相对增加可能为检测小活检标本中的原发性和转移性结肠癌细胞提供一种灵敏的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验